BofA Securities raises Sensata Technologies stock price target to $32

Sensata Technologies (NYSE:ST) saw BofA Securities raise its price target to $32 from $27, while maintaining a Neutral rating, as the firm anticipates Q2 2025 revenue and EPS to exceed Street estimates and company guidance, driven by perceived undervaluation and potential for improved margins from tariff delays. Despite this, the Neutral rating reflects a balance between positive factors like a new CEO and low valuation, and ongoing concerns regarding slow growth and margin improvement. This outlook follows a Q1 2025 period where Sensata reported a revenue decline but surpassed adjusted EPS expectations and achieved a 35% increase in free cash flow.

Analysis

Sensata Technologies (ST) presents a mixed but cautiously optimistic outlook, as reflected by BofA Securities raising its price target to $32.00 while maintaining a Neutral rating. The firm's Q2 2025 revenue and EPS estimates of $939 million and $0.84, respectively, surpass both Street consensus and the company's own guidance, suggesting potential for a near-term earnings beat. A key variable is operating margin, which BofA projects at 18.8%; this could see a modest upside if anticipated tariff pass-through revenues of $10-20 million are lower than guided due to delays. This analyst view is set against a backdrop of challenging fundamentals from Q1 2025, where revenue declined significantly to $911 million from $1,070 million year-over-year. Despite the top-line pressure, Sensata demonstrated operational efficiency by exceeding its adjusted EPS guidance with $0.78 and increasing free cash flow by 35% YoY to $87 million. The Neutral rating from BofA encapsulates this dichotomy, balancing positive catalysts like a new CEO and perceived low valuation against the persistent headwinds of slow growth and margin improvement. The more bullish stance from TD Cowen, with a Buy rating and a $45 price target, highlights the divergent views on the company's strategic and operational adjustments.

Key Decisions for Investors

• Investors should closely monitor the upcoming Q2 earnings report on July 29 for confirmation of the revenue and EPS beat forecasted by BofA, paying particular attention to operating margins and any commentary on tariff impacts.
• Given the conflicting signals of declining top-line revenue versus strong free cash flow generation and an EPS beat, it is prudent to weigh the company's valuation against the tangible risks of slow growth and margin recovery before adjusting positions.
• The significant divergence between BofA's $32 Neutral target and TD Cowen's $45 Buy target suggests that a range-bound or neutral stance may be appropriate until the new management's strategy demonstrates a clear path to accelerating growth.